Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ADVM


Fundamental

Company: Adverum Biotechnologies Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: -
P/E: -
EPS (ttm): -8.57
Insider Own: 25.45%
Shs Outstand: 22.00M
Perf Week: 3.81%
Market Cap: 96.27M
Forward P/E: -
EPS next Y: -5.25
Insider Trans: -7.96%
Shs Float: 16.46M
Perf Month: 1.87%
Enterprise Value: 159.15M
PEG: -
EPS next Q: -1.63
Inst Own: 25.52%
Short Float: 2.65%
Perf Quarter: 25.65%
Income: -184.79M
P/S: -
EPS this Y: -17.07%
Inst Trans: -
Short Ratio: 0.61
Perf Half Y: 46.80%
Sales: 0.00M
P/B: -
EPS next Y Percentage: 32.32%
ROA: -120.47%
Short Interest: 0.44M
Perf YTD: -6.64%
Book/sh: -2.53
P/C: 3.69
EPS next 5Y: -
ROE: -417.79%
52W High: 6.12 -28.76%
Perf Year: -27.33%
Cash/sh: 1.18
P/FCF: -
EPS past 3/5Y: 23.61% 8.03%
ROIC: -672.63%
52W Low: 1.78 144.94%
Perf 3Y: -35.69%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: -48.91% 31.95%
Gross Margin: -
Volatility W: 2.15%
Volatility M: 1.96%
Perf 5Y: -96.82%
Dividend TTM: -
EV/Sales: -
EPS Y/Y TTM: -42.12%
Oper. Margin: -
ATR (14): 0.13
Perf 10Y: -95.84%
Dividend Ex-Date: -
Quick Ratio: 0.65
Sales Y/Y TTM: -100.00%
Profit Margin: -
RSI (14): 58.20
Recom: 3.00
Dividend Gr. 3/5Y: - -
Current Ratio: 0.65
EPS Q/Q: -56.09%
SMA20: 3.35%
Beta: 0.90
Target Price: 5.00
Payout: -
Debt/Eq: -
Sales Q/Q: -100.00%
SMA50: -1.22%
Rel Volume: 0.00
Prev Close: 4.36
Employees: 155
LT Debt/Eq: -
Earnings: Nov 06
SMA200: 25.49%
Avg Volume: 716.52K
Price: 4.36
IPO: Jul 31, 2014
Option/Short: Yes / No
EPS/Sales Surpr.: 11.67% -
Trades:
Volume: 0
Change: 0.00%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z